Liquidia CEO to Participate in Biotech Panel to Explore “How to Create 54 Liquidias”

News | 04. 03. 2012

Liquidia Technologies

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Liquidia Technologies today announced the Company’s CEO, Neal Fowler, will participate in a panel discussion titled “How to Create 54 Liquidias” at the upcoming Nanotech Commercialization Conference (NCC) on April 4th, 2012. The concept of the panel is to explore how North Carolina can further create opportunities and provide resources that will lay the foundation for innovators to build successful companies like Liquidia in the region. The NCC is the preeminent nanotechnology conference in the region and is being held this year in Research Triangle Park, North Carolina April 4-5, 2012.

“Through this panel we want to explore the opportunities that exist for our next generation of innovators and how they too can find success in North Carolina”

Over the next decade, nanotechnology has the potential to influence every aspect of our lives, including our energy, food, medicines, water, buildings, and much, much more. According to a published report by BCC Research, the market value of the worldwide nanomedicine industry is estimated to grow at a CAGR of 12.5% to reach $130.9 billion by the fiscal year 2016. The acceptance and application of nanotechnology to everyday products is a foreshadowing of the growth expected across a multitude of fields including medicine, devices, and diagnostics.

“Liquidia’s success continues to be a shining example of what is possible for startup companies that make roots in North Carolina”, said Jim Roberts, Director of Business Development at COIN, “Through this panel we want to explore the opportunities that exist for our next generation of innovators and how they too can find success in North Carolina”.

Chris William, Managing Director of the Private Client Group at Wells Fargo and Executive Producer of the PBS television series, Carolina Business Review, will host the NCC panel that will also include the Chairman of The Hamner Institutes for Health Sciences, Charles E. Hamner, D.V.M., Ph.D., and Executive Director of the Office of Science & Technology for the North Carolina Department of Commerce, John Hardin. Conference details can be found at


Liquidia Technologies, founded in 2004, is a privately held biotechnology company located in Research Triangle Park, North Carolina. By leveraging precise fabrication techniques of the semiconductor industry, Liquidia has become the only company in the world with the ability to rapidly design and manufacture precisely engineered particles of virtually any size, shape, or composition using a unique particle engineering and manufacturing platform know as PRINT®. This unique ability to precisely engineer particles enables scientists to explore new product frontiers that, until now, have otherwise been out of reach for the life sciences industry. In addition to the development of its own products, Liquidia licenses its PRINT particle technology and its GMP manufacturing capabilities to support proprietary programs advanced by collaborators. For more information, please go to